Search ARM

Publications & Presentations


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.


ARM fosters investment, research & development, commercialization, and access to safe, effective, and transformational treatments and cures.

Webinar & Video Library

June 3, 2020

Value-Based Payments 101

Potentially curative cell and gene therapies are changing the face of medicine and providing hope to patients where there was once none. But how will they be paid for? This webinar discusses the implementation of value-based payment models for innovative therapies.

May 27, 2020

Cell and Gene Therapy Market Access in a COVID-19 World

The webinar includes discussion around how COVID-19 changes the way we think about healthcare decision making and places intense pressure on financial management at all levels of the health system.

May 21, 2020

Cell Therapy Treatments for COVID-19

This webinar highlights potential treatments for Acute Respiratory Distress syndrome (ARDS) in COVID-19 patients. Two therapeutic developers, Athersys and Pluristem Therapeutics, presented on their treatment approaches and plans for near term clinical trials.

ARM provides a library of recordings of panels, company presentations, webinars, and more on our YouTube page.

 

YouTube All Videos & Recordings

ARM Commentary

June 18, 2020

A Wave of New Technology: Gene-Edited Therapies Produce First Clinical Data

May 5, 2020

Creating A Roadmap For The Development And Manufacture Of Gene Therapies

February 28, 2020

Bringing Regenerative Medicines to Patients in Need

January 31, 2020
Cell & Gene Therapy Insights

State of the Industry: The Financial, Clinical, and Scientific Landscape for Cell and Gene Therapies

June 10, 2019
In Vivo

Manufacturing Cures: Infrastructure Challenges Facing Cell And Gene Therapy Developers

May 13, 2019

Update on Regenerative Medicine Advanced Therapies Designations

Sector Presentations

May 11, 2020

Valuing Transformative Therapies

Virtual

Janet Lambert, CEO, ARM

The presentation, which provides an overview on value demonstration for cell and gene therapies, cites information from ARM’s library of original policy analyses.

February 27, 2020

Landscape and Evolution of the Cell & Gene Therapy Marketplace

New York City

Janet Lambert, CEO, ARM

The presentation, which provides an overview of public policy considerations for the cell and gene therapy sector, cites information from ARM’s library of original policy analyses.

February 26, 2020

CAR-TCR Europe 2020: ATMP Market Access

London

Annie Hubert, Sr. Director, European Policy, ARM

This presentation draws on conclusions from ARM’s 2020 position paper on providing cross-border access to ATMPs in Europe, available here.

February 25, 2020

CMC for CAR-T Therapies

London

Michael Lehmicke, Director, Science & Industry Affairs, ARM

Additional information on ARM’s manufacturing initiatives is available here.

February 25, 2020

Cell and Gene Therapy Workshop

New York City

Robert Falb, Director, US Policy & Advocacy, ARM

The presentation provides an overview of the cell and gene therapy sector, with an emphasis on CAR-T therapies and related policy provisions.

February 7, 2020

ATMPs in Europe: State of Play

Berlin, Germany

Annie Hubert, Sr. Director, European Policy, ARM

This presentation provides an overview of the European ATMP sector, including financings, clinical development, and ARM’s European policy priorities.

January 22, 2020

Regenerative Medicine Sector Overview

Miami, FL

Janet Lambert, CEO, ARM

This presentation, which includes data from ARM’s 2019 Global Sector Report, provides an overview of the regenerative medicine and advanced therapy sector for conference attendees.

January 13, 2020

Cell & Gene State of the Industry 2020

San Francisco, CA

Janet Lambert, CEO, ARM

ARM’s annual State of the Industry briefing provides an update on global financings, clinical development, public policy considerations, and other regenerative medicine sector trends. A recording of the presentation is available here.

December 12, 2019

Getting Ready: EU ATMP Access Event

Brussels, Belgium

Janet Lambert, CEO, ARM

This roundtable event brought together sector stakeholders to discuss improved patient access to ATMPs in Europe. The presentation included an overview of ARM’s Getting Ready report.

October 29, 2019

ICMRA October 2019 Meeting

Rome, Italy

Janet Lambert, CEO, ARM & Michael Werner, Sr. Policy Counsel, ARM

ARM provided an overview of regulatory considerations in the US, Europe, and abroad for the International Coalition of Medicines Regulatory Authorities.

October 15, 2019

Advanced Therapies Sector Overview

London, UK

Annie Hubert, Sr. Director, European Policy, ARM

The presentation included an overview of the financial and clinical landscape for the development of gene therapies for rare disorders and policy priorities to promote development and patient access.

October 10, 2019

Gene Therapies: Sector Overview

New York City

Janet Lambert, CEO, ARM

ARM provided an overview of the gene therapy sector for the New York Academy of Sciences, including the clinical landscape for innovative gene-editing technologies.

October 3, 2019

ARM's Role in the Sector

Carlsbad, CA

Janet Lambert, CEO, ARM

This presentation provides an overview of ARM to attendees at the annual Meeting on the Mesa. For more information on the Meeting on the Mesa, click here. A recording of the remarks is available here.

October 2, 2019

Welcome to the Meeting on the Mesa

Carlsbad, CA

Janet Lambert, CEO, ARM

ARM CEO Janet Lambert  annual Meeting on the Mesa. For more information on the Meeting on the Mesa, click here. A recording of the presentation is available here.

September 12, 2019

Cell & Gene Therapy Bioprocessing & Commercialization 2019

Boston, MA
September 12, 2019

Cross-Sector Efforts to Advance Cell & Gene Therapy Manufacturing

Boston, MA
August 27, 2019

Principles for Ethical Application of Gene Editing in the Clinic

Geneva, Switzerland
July 15, 2019

Regenerative Medicine Sector Overview

Boston, MA

Recently Submitted Comments, Letters, Statements